ENSYSCE BIOSCIENCES, INC.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $4.3M | $3.5M | $1.1M | $3.1M | $12.3M | $194.2K | — | — |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $7.2M | $5.3M | $2.3M | $5.3M | $15.7M | $347.9K | $1.2M | $1.9M |
| Property, Plant & Equipment | $124.1K | — | — | — | — | $151 | — | — |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $7.5M | $5.6M | $2.7M | $5.9M | $16.4M | $351.8K | $196.5M | $204.8M |
| Liabilities | ||||||||
| Accounts Payable | $3.3M | $1.4M | $1.9M | $2.9M | $301.1K | $1.7M | $2.8M | $429.2K |
| Total Current Liabilities | $4.6M | $2.2M | $3.3M | $9.5M | $16.5M | $7.0M | $2.8M | $437.9K |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $4.6M | $2.2M | $3.4M | $9.9M | $24.6M | $7.0M | $17.5M | $13.2M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-139.7M | $-129.5M | $-121.6M | $-110.9M | $-85.8M | $-56.0M | $-136.7K | $930.6K |
| Total Stockholders' Equity | $3.2M | $3.7M | $-322.9K | $-3.7M | $-7.9M | $-6.4M | $5.0M | $5.0M |